TrialJournal of the American Society of Nephrology : JASN2016
Four-Week Studies of Oral Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor GSK1278863 for Treatment of Anemia.
Louis Holdstock et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
98 papers cite itlatest 60 shown
this paperpooled ittrialcites it